Watchlist Price Alert

Fennec Pharmaceuticals In... (FENC)

NASDAQ: FENC · Real-Time Price · USD

6.34

0.23 (3.76%)

At close: May 02, 2025, 3:59 PM

6.30

-0.71%

After-hours: May 02, 2025, 04:05 PM EDT

Fennec Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019	Q4 2018	Q3 2018	Q2 2018	Q1 2018	Q4 2017	Q3 2017	Q2 2017	Q1 2017	Q4 2016	Q3 2016	Q2 2016	Q1 2016
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018	Dec 31, 2017	Sep 30, 2017	Jun 30, 2017	Mar 31, 2017	Dec 31, 2016	Sep 30, 2016	Jun 30, 2016	Mar 31, 2016
Net Income	-436K	-1.21M	2.63M	2.74M	-16.1M	-20.2M	-26.44M	-26.07M	-23.71M	-21.28M	-17.38M	-16.31M	-17.35M	-16.16M	-18.17M	-19.02M	-18.11M	-18.48M	-14.09M	-13.97M	-12.78M	-12.15M	-13.09M	-10.95M	-9.89M	-9.19M	-8.8M	-7.81M	-7.05M	-5.9M	-4.05M	-3.17M	-2.79M	-2.19M	-1.81M	-1.26M
Depreciation & Amortization	864K	1.08M	991K	892K	221K	111K	171.4K	258.4K	212.4K	88.4K	36K	22K	16K	410K	757K	787K	804K	420K	82K	69K	64K	46K	29K	12K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Stock-Based Compensation	5.06M	4.79M	3.84M	5.46M	5.35M	5.35M	6.38M	4.84M	4.15M	4.2M	3.23M	3.55M	3.75M	3.42M	3.76M	2.98M	2.79M	2.28M	1.36M	2.81M	2.67M	2.58M	2.51M	1.8M	1.82M	1.4M	2.25M	1.71M	1.46M	2.37M	1.29M	656K	628K	234K	202K	101K
Other Working Capital	7.08M	7.86M	23.93M	25.19M	1.41M	1.98M	1.68M	1.67M	1.61M	490K	43K	-65K	-138K	55K	-598K	-518K	-722K	-433K	18K	-31K	-11K	-69K	-6K	18K	-45K	-166K	7K	-72K	402K	-80K	40K	57K	64K	43K	-5K	26K
Other Non-Cash Items	27.32M	28.05M	6.81M	2.51M	287.01K	223.24K	274K	238K	320K	730K	613K	660K	346K	-6K	341K	287K	486K	837K	499K	486K	481K	318K	1.46M	1.12M	938K	1.2M	227K	671K	931K	423K	249K	163K	27K	-11K	-236K	-655K
Deferred Income Tax	n/a	-73K	-73K	n/a	n/a	73K	12.6K	-60.4K	-66.4K	-74.4K	-61K	-61K	-55K	-449K	-757K	-787K	-804K	-420K	-82K	-69K	-64K	-46K	-29K	-12K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	n/a	-3.17M	14.76M	17.65M	-6.83M	-4.59M	-1.66M	78K	1.1M	1.87M	1.11M	-1.35M	-932K	-1.48M	-2.68M	315K	-763K	1.46M	1.54M	346K	569K	-1.15M	513K	283K	132K	1.21M	420K	736K	1.01M	176K	-10K	56K	10K	26K	-61K	-133K
Operating Cash Flow	27.15M	23.65M	23.13M	27.22M	-17.23M	-19.06M	-21.34M	-20.78M	-18.06M	-14.5M	-12.45M	-13.48M	-14.22M	-14.26M	-16.75M	-15.44M	-15.6M	-13.9M	-10.69M	-10.33M	-9.06M	-10.4M	-9.76M	-8.58M	-7.83M	-6.22M	-5.58M	-4.69M	-3.64M	-2.93M	-2.52M	-2.3M	-2.12M	-1.94M	-1.9M	-1.94M
Capital Expenditures	n/a	n/a	-3.37	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	3.37	3.37	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Debt Repayment	n/a	5.09M	5.09M	5.09M	5.09M	-65K	19.93M	19.93M	19.93M	20M	n/a	5M	5M	5M	5M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	-17K	-50K	-77K	-78K	-89K	-241K	-214K	-194K	-166K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-13.97M	-1.78M	-1.27M	-649.29K	675.71K	1.58M	1.44M	975K	797K	-82K	71K	-7K	-22K	430K	313K	322K	322K	-140K	-23K	n/a	-71K	1.12M	1.6M	2.09M	2.35M	1.24M	1.14M	749K	563K	5.48M	5.1M	5.01M	5.11M	108K	129K	572K
Financial Cash Flow	-13.62M	4.43M	5.16M	5.42M	6.74M	1.73M	21.38M	20.91M	20.73M	19.92M	100.72K	5.02M	5.01M	5.46M	5.31M	32.29M	32.29M	31.83M	31.94M	n/a	-71K	1.12M	1.6M	2.09M	2.35M	21.05M	20.98M	28.16M	27.98M	8.08M	7.67M	5.01M	5.11M	5.11M	5.13M	572K
Net Cash Flow	13.43M	27.97M	28.12M	32.77M	-10.55M	-17.39M	43K	131K	2.67M	5.42M	-12.38M	-8.49M	-9.24M	-8.83M	-11.44M	16.85M	16.69M	17.93M	21.25M	-10.33M	-9.13M	-9.28M	-8.16M	-6.49M	-5.48M	14.84M	15.41M	23.47M	24.33M	5.15M	5.15M	2.71M	2.98M	3.17M	3.23M	-1.37M
Free Cash Flow	27.15M	23.65M	23.13M	27.22M	-17.23M	-19.06M	-21.34M	-20.78M	-18.06M	-14.5M	-12.45M	-13.48M	-14.22M	-14.26M	-16.75M	-15.44M	-15.6M	-13.9M	-10.69M	-10.33M	-9.06M	-10.4M	-9.76M	-8.58M	-7.83M	-6.22M	-5.58M	-4.69M	-3.64M	-2.93M	-2.52M	-2.3M	-2.12M	-1.94M	-1.9M	-1.94M